Skip to main content
Cancers logoLink to Cancers
. 2023 Feb 7;15(4):1035. doi: 10.3390/cancers15041035

Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461

Rie von Eyben 1, Daniel S Kapp 2, Manuela Andrea Hoffmann 3,4, Cigdem Soydal 5, Christian Uprimny 6, Irene Virgolini 6, Murat Tuncel 7, Mathieu Gauthé 8, Finn E von Eyben 9,*
PMCID: PMC9940692  PMID: 36831697

Error in Figure

In the original publication [1], there was a mistake in Figure 6. The lower line that shows the control group treatment is ADT + SDaRT + MDT; however, it should only include ADT + MDT. The corrected Figure 6 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Corrected Figure 6

graphic file with name cancers-15-01035-i001.jpg

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.von Eyben R., Kapp D.S., Hoffmann M.A., Soydal C., Uprimny C., Virgolini I., Tuncel M., Gauthé M., von Eyben F.E. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers. 2022;14:5461. doi: 10.3390/cancers14215461. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES